Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Euro Q1 Consumer Health Earnings Preview: Sanofi, Reckitt, GSK And Bayer

Apr 17 2022

• By Tom Gallen

Q1 written on a speechbubble — • Source: Shutterstock

Related Content

Sanofi Not Distracted By M&A Chatter As It Gets Back On Par With Market Growth

Feb 07 2022

GSK Consumer Split Set For July, With Emerging Markets And Switch To Drive Growth

Mar 01 2022

Reckitt Restructure Seeks To Maximize Dietary Supplement Growth

Feb 22 2022

GSK In 'Countdown Mode' To Consumer Split As Full Year Sales Slip Back

Feb 10 2022

Bayer Beats The Market In 2021 And Has High Hopes For 2022

Mar 02 2022

Sanofi Lawsuit Delays OTC <em>Nasacort</em> Generic Competition

Feb 05 2014

US Q1 Consumer Health Earnings Preview: Pivoting From Planning Changes To Parsing Results

Apr 17 2022

Sanofi Counts On OTC Switches Adding $1bn In Consumer Revenues By 2026

Dec 12 2019

Sanofi Returning Zantac OTC Heartburn Remedy Brand To US Market Formulated With Famotidine

Apr 28 2021

GSK Sees Other Side Of Consumer Health Stockpiling Coin, Looks Ahead To Business Split

Apr 28 2021

Reckitt's OTC Sales Slide 40% In 'Exceptionally Weak' Cold & Flu Season

Apr 28 2021

Bayer Cements Supplement Sales Gains From Initial COVID Boost

May 13 2021

Additional Topics

Europe International Sales & Earnings OTC Drugs Business Strategies Dietary Supplements Market Intelligence Consumer

More from Earnings

More from Business

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window